Abstracts ASN Report 2019

׭٫ ڲ Nuclear medicine 5. asn.fr/Informer/Actualites/Quinze-recommandations-sur-le-deversement-d-eaux-usees-faiblement-contaminees ג ِ׏ ¨ȸƺɀƺȇɎƏɎǣȒȇ Ȓǔ ȇɖƬǼƺƏȸ ȅƺƳǣƬǣȇƺ ƏƬɎǣɮǣɎǣƺɀ Nuclear medicine includes all uses of unsealed radioactive sources for diagnostic or therapeutic purposes. Diagnostic uses can be divided into in vivo techniques, based on administration of radionuclides to a patient, and exclusively in vitro ĴŃŃĿļĶĴŇļłŁņ ҎŀĸķļĶĴĿ ĵļłĿłĺŌҏє ňŁĶŇļłŁĴĿ ĸŋŃĿłŅĴŇļłŁ ĸŋĴŀļŁĴŇļłŁņ can combine in vitro and in vivo techniques. Ł ļŁʼnĸņŇļĺĴŇļłŁ ĶłŁķňĶŇĸķ ļŁ ĸĴŅĿŌ ӅӃӄӋׇŊļŇĻ ĴĿĿ ŇĻĸ ŁňĶĿĸĴŅ medicine units licensed by the ASN regional divisions enabled ĴŁ ļŁʼnĸŁŇłŅŌ łĹ ŇĻĸ ĸńňļŃŀĸŁŇ ŃłłĿ ļŁ ӅӃӄӊׇŇł ĵĸ ķŅĴŊŁ ňŃё ĴŁķ provided information on the number of procedures performed using the different technologies and on the human resources. The ķĴŇĴ ĶłĿĿĸĶŇĸķ ĹłŅ ӅӃӄӊׇĴŅĸ ŃŅĸņĸŁŇĸķ ĵĸĿłŊє According to this investigation, the total annual number of ŁňĶĿĸĴŅ ŀĸķļĶļŁĸ ŃŅłĶĸķňŅĸņ ļŁ ŅĴŁĶĸ ļņ ĴĵłňŇ ӄёӈӆӊёӃӃӃׇłĹ ŊĻļĶĻ ĴĵłňŇ ӌӃӃёӃӃӃׇĴŅĸ ļŁĺĿĸ ĻłŇłŁ ŀļņņļłŁ ĶļŁŇļĺŅĴŃĻŌ Ҏ ҏё ӄӅӈёӃӃӃׇŃŅłĶĸķňŅĸņ ŊļŇĻ ņĸŀļĶłŁķňĶŇłŅ ĶĴŀĸŅĴ ķĸŇĸĶŇļłŁ ĴŁķ ĴĵłňŇ ӈӃӃёӃӃӃׇ łņļŇŅłŁ ŀļņņļłŁ łŀłĺŅĴŃĻŌ Ҏ ҏ ŃŅłĶĸķňŅĸņ (see point 4.1.1.). • zɖƬǼƺƏȸ ȅƺƳǣƬǣȇƺ ƳƺȵƏȸɎȅƺȇɎɀ Ň ŇĻĸ ĸŁķ łĹ ӅӃӄӌё ŇĻļņ ņĸĶŇłŅ łĹ ĴĶŇļʼnļŇŌ ĶłŀŃŅļņĸņ ӅӆӆׇŁňĶĿĸĴŅ medicine units; the number of Internal Targeted Radiotherapy Ҏ ҏ Ņłłŀņ ļņ ņŇĴĵĿĸё ʼnĴŅŌļŁĺ ĹŅłŀ ӄӈӋׇŇł ӄӈӈє These units group the patient management facilities ( in vivo diagnosis) and in a small number of them, a medical biology activity using unsealed sources ( in vitro diagnosis). Lastly, slightly ŀłŅĸ ŇĻĴŁ ӋӃׇķĸŃĴŅŇŀĸŁŇņ ŃĴŅŇļĶļŃĴŇĸ ļŁ ŅĸņĸĴŅĶĻ ŃŅłŇłĶłĿņ involving humans. Some fifty in vitro diagnostic laboratories were inventoried by ASN ļŁ ӅӃӄӌё ĵňŇ ŇĻļņ ŁňŀĵĸŅ ļņ ŇĸŁķļŁĺ Ňł ķŅłŃ ķňĸ Ňł ŇĻĸ ĺŅĴķňĴĿ phasing out of this activity in favour of analysis methods that do not use radionuclides. Ļĸ ŅĸĺļłŁĴĿ ķļʼnļņļłŁņ ļņņňĸķ ӄӆӆׇŁňĶĿĸĴŅ ŀĸķļĶļŁĸ ĿļĶĸŁņĸņ ļŁ ӅӃӄӌє ĻĸŌ ĶłŁĶĸŅŁĸķ ŀłŅĸ ņŃĸĶļĹļĶĴĿĿŌ ĶĻĴŁĺĸņ łĹ ĶĴŀĸŅĴņ or license extensions to permit the use of new radionuclides. • xƺƳǣƬƏǼ ƳǣɀȵƺȇɀƏȸǣƺɀ When a medical dispensary is authorised in a health care centre, the room in the nuclear medicine department in which the radiopharmaceutical drugs are prepared, called the “nuclear pharmacy” or “radiopharmacy”, is part of the medical dispensary. ĻĸŅĸ ĴŅĸ ӄӅӋׇŁňĶĿĸĴŅ ŃĻĴŅŀĴĶļĸņ ĴŀłŁĺ ŇĻĸ ӅӆӆׇŁňĶĿĸĴŅ medicine units in public health care institutions and non-profit private health care institutions, such as the cancer centres. The radio-pharmacist is primarily responsible for managing the radiopharmaceutical drug circuit (procurement, possession, preparation, control, dispensing and traceability) and the quality of preparation. The radiopharmacist may be assisted by hospital pharmacy dispensers or radiographers. • Áǝƺ ƺȷɖǣȵȅƺȇɎ Apart from the cameras used in the nuclear medicine units, some ӇӃӃׇŅĴķļĴŇļłŁіŃŅłłĹ ĸŁĶĿłņňŅĸņ ĴŅĸ ļŁņŇĴĿĿĸķ ļŁ ŇĻĸ ķĸŃĴŅŇŀĸŁŇņё ķļʼnļķĸķ ŅłňĺĻĿŌ ĸńňĴĿĿŌ ĵĸŇŊĸĸŁ ѢĿłŊ ĸŁĸŅĺŌѣ ҎӄׇŇł ӅׇŃĸŅ ķĸŃĴŅŇі ŀĸŁŇҏ ĴŁķ ѢĻļĺĻ ĸŁĸŅĺŌѣ ҎӄׇŇł ӉׇŃĸŅ ķĸŃĴŅŇŀĸŁŇҏ ĸŁĶĿłņňŅĸņє ĻĸŅĸ ĴŅĸ ĴĿņł ŁĸĴŅĿŌ ӄӄӃׇĴňŇłŀĴŇĸķ łŅ ņĸŀļіĴňŇłŀĴŇĸķ ķĸʼnļĶĸņ ĹłŅ ŃŅĸŃĴŅļŁĺ ŅĴķļłŃĻĴŅŀĴĶĸňŇļĶĴĿņ ŀĴŅľĸķ ŊļŇĻ ĹĿňłŅļŁĸіӄӋׇĴŁķ ĴĵłňŇ ӉӃׇĴňŇłŀĴŇĸķ ļŁĽĸĶŇļłŁ ķĸʼnļĶĸņє • xƏȇƏǕƺȅƺȇɎ Ȓǔ ƺǔǔǼɖƺȇɎɀ ǔȸȒȅ ȇɖƬǼƺƏȸ ȅƺƳǣƬǣȇƺ ƳƺȵƏȸɎȅƺȇɎɀ Ļĸ ӄӈׇŅĸĶłŀŀĸŁķĴŇļłŁņ łĹ ŇĻĸ ŅĸŃłŅŇ (5) of the Working Group “Discharging into the sewage networks of effluents containing radionuclides from nuclear medicine departments and research ĿĴĵłŅĴŇłŅļĸņѣ Ҏ ҏ ŊĸŅĸ ŃňĵĿļņĻĸķ ļŁ ňŁĸ ӅӃӄӌׇłŁ asn.fr . The principal objectives of these recommendations are to: ҄ allow the updating of the contaminated effluents discharge ĴňŇĻłŅļņĴŇļłŁņ ŃŅłʼnļķĸķ ĹłŅ ļŁ ŅŇļĶĿĸ єׇӄӆӆӄіӄӃׇłĹ ŇĻĸ Public Health Code, issued by the authorities responsible for managing the collective public sewage network; GRAPH 8 Percentage of conformity of the facilities concerning the management of events giving rise to corrective actions in 2019 0% 10% 20% 30% 40% 50% 60% 70% 80% 90% 100% Reporting culture and organization ȇƏǼɵɀǣɀً ƳƺˡȇǣȇǕ ƬȒȸȸƺƬɎǣɮƺ ƏƬɎǣȒȇɀً building on lessons learned ɀɀƺɀɀǣȇǕ ƬȒȸȸƺƬɎǣɮƺ ƏƬɎǣȒȇ ƺǔǔƺƬɎǣɮƺȇƺɀɀ R(« ɮƏǼǣƳƏɎǣȒȇ ȵȸȒƬƺƳɖȸƺ and traceability 212 ASN Report on the state of nuclear safety and radiation protection in France in 2019 ׎ ٲ ו MEDICAL USES OF IONISING RADIATION